Literature DB >> 31788844

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

Paul J Hampel1, Timothy G Call1, Wei Ding1, Eli Muchtar1, Saad S Kenderian1, Yucai Wang1, Jose F Leis2, Thomas E Witzig1, Amber B Koehler1, Amie L Fonder1, Susan M Schwager3, Kari G Rabe3, Daniel L Van Dyke4, Esteban Braggio2, Susan L Slager3, Neil E Kay1, Sameer A Parikh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31788844     DOI： 10.1002/ajh.25690

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: "What's Past Is Prologue" (Shakespeare).

Authors:  Anthony R Mato; Matthew S Davids; Jeff Sharman; Lindsey E Roeker; Neil Kay; Arnon P Kater; Kerry Rogers; Meghan C Thompson; Joanna Rhodes; Andre Goy; Alan Skarbnik; Stephen J Schuster; Constantine S Tam; Toby A Eyre; Susan O'Brien; Chadi Nabhan; Nicole Lamanna; Clare Sun; Mazyar Shadman; John M Pagel; Chaitra Ujjani; Danielle Brander; Catherine C Coombs; Nitin Jain; Chan Y Cheah; Jennifer R Brown; John F Seymour; Jennifer A Woyach
Journal:  Clin Cancer Res       Date:  2022-02-15       Impact factor: 13.801

Review 2.  Agony of choice-selecting chronic lymphocytic leukemia treatment in 2022.

Authors:  Jan-Paul Bohn
Journal:  Memo       Date:  2022-04-14

3.  An 81-Year-Old Man with a 6-Year History of Chronic Lymphocytic Leukemia Presenting with Disease Flare Following Ibrutinib Discontinuation.

Authors:  Stefano Pozzi; Leonardo Potenza; Davide Giusti; Elisabetta Colaci; Valeria Pioli; Giovanna Leonardi; Monica Maccaferri; Mario Luppi; Roberto Marasca
Journal:  Am J Case Rep       Date:  2022-08-26

4.  Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy.

Authors:  Joshua N Gustine; Shayna Sarosiek; Catherine A Flynn; Kirsten Meid; Carly Leventoff; Timothy White; Maria Luisa Guerrera; Lian Xu; Amanda Kofides; Nicholas Tsakmaklis; Manit Munshi; Maria Demos; Christopher J Patterson; Xia Liu; Guang Yang; Zachary R Hunter; Andrew R Branagan; Steven P Treon; Jorge J Castillo
Journal:  Haematologica       Date:  2022-05-01       Impact factor: 11.047
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.